
Quest Diagnostics Incorporated DGX
$ 195.58
0.91%
Quarterly report 2026-Q1
added 04-22-2026
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
111 M |
Market Cap[1] |
$ 21.7 B |
EBITDA (LTM) |
$ 2.14 B |
P/E (LTM) |
21.37 |
P/S (LTM) |
1.9 |
EPS (LTM) |
8.93 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Celcuity
CELC
|
$ 90.11 | 1.3 % | $ 4.21 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 5.89 | 13.93 % | $ 7.83 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 21.55 | 5.69 % | $ 625 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 19.57 | 7.88 % | $ 602 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 132.64 | 4.42 % | $ 16.6 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 152.45 | 5.94 % | $ 12 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 23.4 | 4.86 % | $ 1.25 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 167.06 | -2.26 % | $ 25.9 B | Nasdaq Global Select Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.72 | -1.47 % | $ 7.61 M | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 180.76 | 0.91 % | $ 24.3 B | NYSE,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 101.94 | 1.69 % | $ 6.88 B | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 11.51 | 13.51 % | $ 1.47 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 184.88 | 2.68 % | $ 9.16 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 224.15 | 5.81 % | $ 30.6 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 457.7 | 1.53 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 19.73 | 3.62 % | $ 442 M | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 4.68 | 6.25 % | $ 433 M | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 12.18 | 12.99 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.98 | 2.44 % | $ 24.6 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 6.94 | 3.27 % | $ 290 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.17 | 2.84 % | $ 4.98 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 260.68 | 0.69 % | $ 21.7 B | NYSE,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 75.91 | 4.95 % | $ 4.54 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 480.44 | 1.35 % | $ 181 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.7 | -0.11 % | $ 251 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.07 | 3.01 % | $ 1.97 B | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 377.4 | -0.61 % | $ 22.5 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.